Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Glaxo Linked Investigators Indicted In China For Illegal Investigation

Mon, 14th Jul 2014 07:45

LONDON (Alliance News) - China has indicted a British-American couple for illegally obtaining private information of Chinese citizens. The couple, Peter William Humphrey, a 58-year-old British national, and his wife Yu Ying Zeng, a 61-year old American, were arrested in last year. They were hired by GlaxoSmithKline PLC China's Mark Reilly as private eyes in 2013.

Prosecutors in Shanghai have found that the couple illegally trafficked a huge amount of personal information on Chinese citizens to seek profits through a company called ChinaWhys Co Ltd, which was registered in 2004 in Shanghai.

The personal information traded by the couple included household registration details, background of family members, real estate, vehicles, call log and exit-entry records. The couple also obtained the information by means such as secret photography, infiltration or tailing after someone.

It is the first indictment Chinese prosecutors have announced on foreigners for illegal investigation.

The couple compiled so-called "reports" and sold them at high prices to their clients, most of which are China-based multinational corporations, including Glaxo's Chinese operations.

Humphrey said that in April 2013 he was contacted by Mark Reilly, then Glaxo China's general manager and Zhao Hongyan, its legal department director and was prepaid CNY100,000. Reilly asked him to find the informant who disclosed Glaxo China's bribery scandals to Chinese authorities and Glaxo's executives.

Humphrey said that after the investigation, he found the bribery claim was valid based on his work experience of about a dozen years. He felt he was "betrayed and used" and Glaxo China's suspicions about the informant was "unfounded."

Humphrey also admitted to having used illegal means to do his investigation, including buying others' information and tailing after them.

Copyright RTT News/dpa-AFX

Related Shares

More News
Today 08:25

Merck KGaA shares plunge after cancer drug hopeful fails

FRANKFURT, June 25 (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a ...

24 Jun 2024 08:55

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU

(Alliance News) - GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU.

24 Jun 2024 07:43

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal

(Alliance News) - London's FTSE 100 is called to open lower at the start of the week, with share price falls for major US tech shares, Nvidia included...

24 Jun 2024 07:21

GSK reports regulatory progress for Omjjara, Jemperli

(Sharecast News) - GSK announced on Monday that it has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for 'Omjjara', or ...

20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has rece...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.